GEODE CAPITAL MANAGEMENT, LLC

Position in GRAL — GRAIL, Inc.

CIK 1214717 BOSTON, MA

Position in GRAL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$42,788,042

-$25,812,599 QoQ

Shares Held

827,942

+3.3% QoQ

Ownership

1.93%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $15,360,896,443 across 43 Diagnostics & Research names. GRAL ranks #21 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	8,407,891	$4,132,730,662
2	DHR	Danaher Corp /De/	14,145,758	$2,682,035,716
3	IDXX	Idexx Laboratories Inc /De	2,660,999	$1,495,188,727
4	A	Agilent Technologies, Inc.	7,522,028	$857,360,751
5	WAT	Waters Corp /De/	2,646,458	$788,115,192
6	MTD	Mettler Toledo International Inc/	605,739	$763,958,026
7	IQV	Iqvia Holdings Inc.	4,463,052	$761,128,887
8	DGX	Quest Diagnostics Inc	3,086,308	$604,854,641

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,788,042	827,942	+3.3%	Shares	Defined	2026-05-15
2025-12-31	$68,600,641	801,503	+9.8%	Shares	Defined	2026-02-09
2025-09-30	$43,179,682	730,250	-3.6%	Shares	Defined	2025-11-12
2025-06-30	$38,964,532	757,770	+60.4%	Shares	Defined	2025-08-08
2025-03-31	$12,066,091	472,439	+6.5%	Shares	Defined	2025-05-13
2024-12-31	$7,917,599	443,563	+4.6%	Shares	Defined	2025-02-12
2024-09-30	$5,833,881	423,974	+0.5%	Shares	Defined	2024-11-12
2024-06-30	$6,482,573	421,768	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.